Dapagliflozin restores autophagy and attenuates apoptosis via the AMPK/mTOR pathway in diabetic nephropathy rats and high glucose-induced HK-2 cells

被引:0
作者
Ye, Yu-Yan [1 ]
Chen, Yun [1 ]
Yang, Jing [1 ]
Wu, Jie [2 ]
Wang, Peng [3 ]
机构
[1] Jinhua Peoples Hosp, Dept Nephrol, Jinhua 321000, Zhejiang, Peoples R China
[2] Jinhua Peoples Hosp, Dept Cardiovasc Med, Jinhua, Zhejiang, Peoples R China
[3] Jinhua Peoples Hosp, Dept Pharm, Jinhua, Zhejiang, Peoples R China
关键词
Diabetic nephropathy; Dapagliflozin; Autophagy; AMPK;
D O I
10.1007/s11255-024-04172-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PurposeDiabetic nephropathy (DN) is a serious microvascular complication of diabetes mellitus. Significantly reduced levels of autophagy in diabetic kidneys play an important role in the development of DN. The present study investigated the effects of dapagliflozin (DAP) on renal autophagy and AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) pathway in vivo and in vitro.MethodsWe explored the effect of DAP in streptozotocin (STZ)-induced DN rats. The anti-DN effect of DAP was assessed by body weight, kidney weight/body weight ratio, blood and urine biochemical parameters, and pathological changes of kidney tissue. Number of autophagosomes in the kidney was investigated through Transmission electron microscopy. Besides, cell viability and apoptosis of DAP alone or combined with Compound C (CC, a selective AMPK inhibitor)-treated high glucose (HG)-induced HK-2 cells were detected by Cell Counting Kit-8 (CCK-8) and flow cytometry assays. Immunohistochemistry, Western blot, Enzyme-linked immunosorbent assay (ELISA), and immunofluorescence were employed to detect the expression levels of extracellular matrix (ECM) deposition, autophagy, apoptosis, and AMPK/mTOR pathway-associated targets in vivo and in vitro.ResultsThe results showed that DAP ameliorated the body weight and decreased kidney weight, fasting blood glucose, and serum/urine biochemical parameters of renal damage, as well as renal pathological changes. Moreover, DAP significantly ameliorated HG-induced cell apoptosis and ECM deposition in HK-2 cells. However, these favorable effects of DAP could be abolished by co-treatment with CC in HG-induced HK-2 cells. Mechanistically, DAP can enhance autophagy in DN including increased LC3-II/I ratio, Beclin-1, p-AMPK protein levels, and decreased p62 and p-mTOR protein expressions, as well as inhibited renal fibrosis and apoptosis.ConclusionIn summary, DAP alleviated fibrosis, apoptosis, and autophagy in DN rats and HG-induced HK-2 cells by regulating the AMPK/mTOR pathway.
引用
收藏
页码:249 / 261
页数:13
相关论文
共 40 条
  • [1] SGLT2 Inhibition for the Prevention and Treatment of Diabetic Kidney Disease: A Review
    Alicic, Radica Z.
    Johnson, Emily J.
    Tuttle, Katherine R.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 72 (02) : 267 - 277
  • [2] Diabetic Kidney Disease Challenges, Progress, and Possibilities
    Alicic, Radica Z.
    Rooney, Michele T.
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12): : 2032 - 2045
  • [3] An overview of autophagy: Mechanism, regulation and research progress
    Cao, Weiya
    Li, Jinhong
    Yang, Kepeng
    Cao, Dongli
    [J]. BULLETIN DU CANCER, 2021, 108 (03) : 304 - 322
  • [4] circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells
    Chen, Bin
    Li, Yanhua
    Liu, Yang
    Xu, Zhonggao
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (11) : 21249 - 21259
  • [5] IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
    Cho, N. H.
    Shaw, J. E.
    Karuranga, S.
    Huang, Y.
    Fernandes, J. D. da Rocha
    Ohlrogge, A. W.
    Malanda, B.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 138 : 271 - 281
  • [6] Autophagy in diabetic nephropathy
    Ding, Yan
    Choi, Mary E.
    [J]. JOURNAL OF ENDOCRINOLOGY, 2015, 224 (01) : R15 - R30
  • [7] SGLT2 Inhibitors: Nephroprotective Efficacy and Side Effects
    Garofalo, Carlo
    Borrelli, Silvio
    Liberti, Maria Elena
    Andreucci, Michele
    Conte, Giuseppe
    Minutolo, Roberto
    Provenzano, Michele
    De Nicola, Luca
    [J]. MEDICINA-LITHUANIA, 2019, 55 (06):
  • [8] Role of AMPK mediated pathways in autophagy and aging
    Ge, Yuchen
    Zhou, Min
    Chen, Cui
    Wu, Xiaojian
    Wang, Xiaobo
    [J]. BIOCHIMIE, 2022, 195 : 100 - 113
  • [9] Autophagy and its therapeutic potential in diabetic nephropathy
    Han, Yu-Peng
    Liu, Li-Juan
    Yan, Jia-Lin
    Chen, Meng-Yuan
    Meng, Xiang-Fei
    Zhou, Xin-Ru
    Qian, Ling-Bo
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [10] Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
    Hu, Qichao
    Chen, Yuan
    Deng, Xinyu
    Li, Yubing
    Ma, Xiao
    Zeng, Jinhao
    Zhao, Yanling
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 159